首页> 美国卫生研究院文献>BMC Public Health >Act local think global: how the Malawi experience of scaling up antiretroviral treatment has informed global policy
【2h】

Act local think global: how the Malawi experience of scaling up antiretroviral treatment has informed global policy

机译:采取当地行动放眼全球:马拉维扩大抗逆转录病毒治疗的经验如何为全球政策提供依据

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The scale-up of antiretroviral therapy (ART) in Malawi was based on a public health approach adapted to its resource-poor setting, with principles and practices borrowed from the successful tuberculosis control framework. From 2004 to 2015, the number of new patients started on ART increased from about 3000 to over 820,000. Despite being a small country, Malawi has made a significant contribution to the 15 million people globally on ART and has also contributed policy and service delivery innovations that have supported international guidelines and scale up in other countries. The first set of global guidelines for scaling up ART released by the World Health Organization (WHO) in 2002 focused on providing clinical guidance. In Malawi, the ART guidelines adopted from the outset a more operational and programmatic approach with recommendations on health systems and services that were needed to deliver HIV treatment to affected populations. Seven years after the start of national scale-up, Malawi launched a new strategy offering all HIV-infected pregnant women lifelong ART regardless of the CD4-cell count, named Option B+. This strategy was subsequently incorporated into a WHO programmatic guide in 2012 and WHO ART guidelines in 2013, and has since then been adopted by the majority of countries worldwide. In conclusion, the Malawi experience of ART scale-up has become a blueprint for a public health response to HIV and has informed international efforts to end the AIDS epidemic by 2030.
机译:马拉维扩大抗逆转录病毒疗法(ART)的基础是一种适应其资源匮乏环境的公共卫生方法,并借鉴了成功的结核病控制框架中的原则和实践。从2004年到2015年,开始接受抗逆转录病毒治疗的新患者人数从约3000人增加到820,000多人。尽管是一个小国,但马拉维为全球1500万人的抗逆转录病毒疗法做出了重大贡献,并为支持国际准则并在其他国家扩大规模的政策和服务提供创新做出了贡献。世界卫生组织(WHO)在2002年发布了第一套扩大抗逆转录病毒疗法的全球指南,重点是提供临床指南。在马拉维,ART准则从一开始就采用了更具操作性和计划性的方法,并提出了向受影响人群提供HIV治疗所需的卫生系统和服务方面的建议。在开始全国扩大规模的七年后,马拉维启动了一项新战略,为所有感染了HIV的孕妇提供终生抗病毒治疗,而不论CD4细胞数量如何,都称为Option B +。此策略随后在2012年被纳入WHO计划指南和2013在WHO ART指南中,此后被全世界大多数国家所采用。总之,马拉维扩大抗逆转录病毒疗法的经验已成为公共卫生部门应对艾滋病毒的蓝图,并为国际社会在2030年前终结艾滋病流行做出了努力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号